Table 2.
Distribution of case controls by FDG and iodinated contrast administration
| 18F-FDG administration | Cases (n = 211) | Controls (n = 422) | OR [95%CI] | p |
|---|---|---|---|---|
| Venous access, n= (%) | ||||
| Proximal1 | 199 (94.3) | 356 (84.4) | 3.13 (1.67–7.14) | < 0.001 |
| Distal2 | 9 (4.3) | 57 (13.5) | 0.29 (0.13–0.59) | < 0.001 |
| Permanent device | 3 (1.4) | 9 (2.1) | ||
| NMT in charge (n = 47) | 0.994 | |||
| Injection-acquisition delay (min) | 60.6 ± 3.2 | 61.0 ± 4.6 | 0.265 | |
| Injected activity in MBq (mCi) |
206.8 ± 47.8 (5.6 ± 1.3) |
211.4 ± 49.1 (5.7 ± 1.3) |
0.266 | |
| Iodinated contrast administration | ||||
| Yes | 145 (68.7) | 268 (63.5) | 1.26 (0.89–1.80) | 0.1941 |
| No | 66 (31.3) | 154 (36.5) | 0.79 (0.56–1.13) | |
NMT = nuclear medicine technologist
1elbow, arm; 2forearm, wrist, hand, foot